Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) plus Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial

被引：0
|
作者：
Polonsky, William H.
Mccrimmon, Rory J.
Whitmire, Katherine H.
Giorgino, Francesco
Chen, Jung-Fu
Nicholls, Charlie
Lew, Elisheva
Alvarez, Agustina
Coudert, Mathieu
Rosenstock, Julio
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-747-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
747-P
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial
    Rosenstock, Julio
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Trescoli, Carlos
    Al Sifri, Saud N.
    Lalic, Nebojsa
    Alvarez, Agustina
    Picard, Pascaline
    Demil, Nacima
    Bonnemaire, Mireille
    McCrimmon, Rory J.
    [J]. DIABETES, 2021, 70
  • [2] Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial
    Polonsky, William H.
    Giorgino, Francesco
    Rosenstock, Julio
    Whitmire, Katherine
    Lew, Elisheva
    Coudert, Mathieu
    Alvarez, Agustina
    Nicholls, Charlie
    McCrimmon, Rory J.
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (12): : 2364 - 2372
  • [3] Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe
    Fonseca, Vivian
    Rosenstock, Julio
    Cheng, Alice Y.
    Emral, Rifat
    Sauque-Reyna, Leobardo
    Mohan, Viswanathan
    Al Sifri, Saud N.
    Alvarez, Agustina
    Djaballah, Khier
    Picard, Pascaline
    Souhami, Elisabeth
    Mccrimmon, Rory J.
    [J]. DIABETES, 2021, 70
  • [4] Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe
    Cheng, Alice Y.
    Mccrimmon, Rory J.
    Fonseca, Vivian
    Trescoli, Carlos
    Haluzik, Martin
    Seufert, Jochen
    Alvarez, Agustina
    Souhami, Elisabeth
    Picard, Pascaline
    Bonnemaire, Mireille
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [5] Advancing therapy in basal insulin users with type 2 diabetes: better clinical outcomes with iGlarLixi vs premix BIAsp 30 in the SoliMix trial
    Trescoli, C.
    Rosenstock, J.
    Emral, R.
    Sauque-Reyna, L.
    Mohan, V.
    Al Sifri, S.
    Lalic, N.
    Alvarez, A.
    Picard, P.
    Demil, N.
    Bonnemaire, M.
    McCrimmon, R. J.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 111 - 111
  • [6] Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Nocturnal Hypoglycemia in the SoliMix Trial
    Mccrimmon, Rory J.
    Cheng, Alice Y.
    Fonseca, Vivian
    Choza, Ricardo
    Alessa, Thamer
    Alvarez, Agustina
    Souhami, Elisabeth
    Boss, Anders H.
    Picard, Pascaline
    Rosenstock, Julio
    [J]. DIABETES, 2021, 70
  • [7] Patient-Reported Outcomes (PROs) in Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus (BB) Therapy in Patients (Pts) with Type 2 Diabetes (T2D): DUAL VII Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Kirstine Busk, Anne
    Basse, Amaury
    Jodar, Esteban
    [J]. DIABETES, 2017, 66 : LB32 - LB32
  • [8] iGlarLixi vs. Premixed Insulin Initiation in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: SoliComplex Real-World Study
    Lajara, Rosemarie
    Heller, Caroline
    Pantalone, Kevin M.
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    [J]. DIABETES, 2022, 71
  • [9] iGlarLixi vs. Basal-Bolus (BB) or Premixed Insulin in Older Adult Ethnic Minorities with Type 2 Diabetes (T2D)
    Umpierrez, Guillermo
    Gill, Jasvinder
    Hood, David
    Li, Xuan
    Nunez, Ana
    [J]. DIABETES, 2024, 73
  • [10] Initiation of iGlarLixi vs. Basal-Bolus Insulin (BB) in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: The SoliComplex Real-World Study
    Pantalone, Kevin M.
    Heller, Caroline
    Lajara, Rosemarie
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    [J]. DIABETES, 2022, 71
12345